EDITOR’S NOTE AND SALES OFFICE

Editor’s Note COVID-19 limelight the $35 billion vaccine market

This information came as a surprise to me as I did some research on this topic. As of this script, the coronavirus, or COVID-19, has spread to 28 countries, with over 76,000 infected. These numbers will only continue to grow, as the threat of a global pandemic is now upon us.

On the backdrop of the epidemic, the vaccine market has grown six fold over the past two decades, worth more than $35 billion today, according to AB Bernstein.

EDITORIAL Yi An Ang Editorial Assistant E: angyian1998@gmail.com

Alison Yeo Editor E: design@harvest-info.com

WORLDWIDE SALES OFFICES Japan Katsuya Watanabe T: +81 90 5321 6881 F: +81 3 6823 8994 E: kwatanab@crocus.ocn.ne.jp

AUSTRIA, GERMANY & SWITZERLAND Erhardt Eisenacher T: +49 2 28 2499860 F: +49 2 28 650076 E: info@eisenacher-medien.de

SCANDINAVIA Bob Warren T: +44 (0) 1442 87 77 77 F: +44 (0) 1442 87 06 17 E: bobw@lansdowne-media.co.uk

UNITED KINGDOM, BENELUX, FRANCE & ITALY Stuart Payne T: +44 1932 564999 F: +44 1932 564998 E: stuart.payne@husonmedia.com

NORTH AMERICA USA East Coast Jim Lees T: +1 610 626 0540 F: +1 610 626 0566 E: jameslees@prodigy.net

USA West Coast Wayne Wiggins T: +1 415 387 7784 F: +1 415 387 7855 E: w.wigginsjr@mindspring.com

ISSN 2010-4200

The coronavirus outbreak is bringing attention to the fast-growing vaccine industry. The vaccine market has grown six fold over the past two decades, worth more than $35 billion today, according to AB Bernstein. The firm said the industry has consolidated to four big players that account for about 85% of the market — British drug maker GlaxoSmithKline, French pharmaceutical company Sanofi, and U.S.-based Merck and Pfizer.

“For every dollar invested in vaccination in the world’s 94 lowest-income countries, the net return is $44. Hard to argue against,” Wimal Kapadia, Bernstein’s analyst, said in a note. “This oligopoly has been built through significant market consolidation driven primarily by the complexities of the manufacturing and supply chain.”

These companies have jumped into the race to combat the deadly coronavirus, working on vaccine or drug programs. Investors have been flocking to some biotech names amid market volatility in hopes that their initiatives to develop treatment and prevention for the coronavirus could come to fruition at some point.

“Vaccines are long-lived assets, have high barriers to entry, typically stable/ growing pricing, mostly limited competition and no patent cliff,” Kapadia added.

To be sure, while vaccine companies can see periods of high growth, real innovation is needed to be long-standing winners in a market that requires major capital and faces cheaper alternatives from emerging markets, the analyst cautioned.

Dear Readers, do get acquainted to us as we have so much more to share with industry professionals like you. We discuss food processing, packaging, ingredient, sustainable food, nutrition, supplements, medical breakthroughs, innovation, technology, applications and more ……

Sustainability itself is a profound topic in the 21st Century. It can refer generally to the capacity for the biosphere and human civilization to coexist. It is also defined as the process of people maintaining change in a homeostasis balanced environment, in which the exploitation of resources, the direction of investments, the orientation of technological development and institutional change are all in harmony and enhance both current and future potential to meet human needs and aspirations.

Yes, there is awful of space for more discussions and room for government, pharmaceutical companies, suppliers, developers and others to be seen, and your message to be delivered to the right audience in Asia Food Journal. Come; take advantage of AFJ and write me a note about your possible promotion plans to editorial@harvest-info.com . We promise to assist you.

K. Dass Publisher/Editor-In-Chief, Asia Food Journal

BREAKING NEWS

HARVEST INFORMATION has officially acquired Asia Food Journal. All correspondence should be made to design@harvest-info.com or editorial@harvest-info.com from 30 May 2019. You could also reach us at +65 68289333.

Check us out online!

www.asiafoodjournal.com

HARVEST INFORMATION PTE LTD

120 LOWER DELTA ROAD #09-07 CENDEX CENTER, SINGAPORE 169208 TEL: +65 6828 9333

ASIA FOOD JOURNAL is published six times a year by Harvest Information Pte Ltd, located at 120 Lower Delta Road, #09-07 Cendex Center, Singapore 169208. All rights reserved. Please address all subscription mail to ASIA FOOD JOURNAL at the above address, or Tel +65 6828 9333. For annual air-speeded subscriptions for non-qualified subscribers, please contact Circulation department at editorial@harvest-info. com.com. ASIA FOOD JOURNAL Volume 15, Number 1.

Contents

INGREDIENT

04 One ingredient, endless possibilities

05 Lycored’s new Lumenato (TM) harnesses the natural power of tomatoes for beauty

06 Prinova Europe showcased solutions for every life stage at FIE

07 Tate & Lyle partners with Zymtronix to leverage novel enzyme immobilization technologies

INNOVATION

08 Vertical instead of horizontal: how motion plastics make agriculture sustainable

09 Ruby, a breakthrough innovationt

10 Kerry releases ProDiem Refresh

COVER STORY

14 BookDoc – adding value to healthcare platform

PACKAGING

15 Syntegon Technology: New standards for sustainable materials in horizontal flow wrapping

16 2020 and beyond: Key trends impacting the labelling market

FEATURE

17 Global whole grain & high fiber foods market revenue expected to grow at a significant CAGR, owing to growth witnessed by the health and wellness segment

18 The Asia Food Challenge reports $800 billion investment opportunity in Asia’s AgriFood sector over the next decade

19 Rising Trends And Challenges In The Global Meat & Poultry Industry

IN EVERY ISSUE

01 EDITOR’S NOTE AND SALES OFFICE 12 PEOPLE 21 REVIEW

INGREDIENT

ENZYME IMMOBILIZATION TECHNOLOGIES PG 07

INNOVATION

RUBY PG 09

COVER

BOOKDOC PG 14

PACKAGING

2020 AND BEYOND PG 16

FEATURE

MEAT & POULTRY PG 19